fasudil has been researched along with malondialdehyde in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babül, A; Celik, A; Demiryürek, AT; Demiryürek, S; Kara, AF; Tarakçioglu, M | 1 |
| Chu, L; Guan, SJ; Guo, QY; Ji, ES; Liang, F; Ma, ZH; Wang, JY; Weiss, JW; Wu, YL; Zhang, JP | 1 |
| Chen, S; Dong, K; Li, Z; Liu, M; Wang, Y; Zhang, B; Zheng, L; Zheng, W | 1 |
| Abdali, NT; Ibrahim, TM; Said, E; Yaseen, AH | 1 |
| Dou, Q; Fu, X; Huang, Z; Li, Y; Lin, J; Tao, W; Wang, P; Wei, J; Zhang, W | 1 |
5 other study(ies) available for fasudil and malondialdehyde
| Article | Year |
|---|---|
Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Anesthesia; Animals; Blood Pressure; Carbachol; Cardiotonic Agents; Coronary Vessels; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Intracellular Signaling Peptides and Proteins; Ischemic Preconditioning, Myocardial; Lactates; Male; Malondialdehyde; Myocardial Infarction; Neutrophils; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; rho-Associated Kinases; Tachycardia, Ventricular; Vasodilation; Ventricular Premature Complexes | 2005 |
Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Apoptosis; Blood Glucose; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enzyme Inhibitors; Hemodynamics; In Situ Nick-End Labeling; Male; Malondialdehyde; Microscopy, Electron, Transmission; Myocardium; Organ Size; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; Superoxide Dismutase | 2012 |
Fasudil reversed MCT-induced and chronic hypoxia-induced pulmonary hypertension by attenuating oxidative stress and inhibiting the expression of Trx1 and HIF-1α.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hemodynamics; Hydrogen Peroxide; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Malondialdehyde; Monocrotaline; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thioredoxins; Vasodilator Agents | 2014 |
Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alanine Transaminase; Animals; Aorta; Aspartate Aminotransferases; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Creatine Kinase; Glutathione; Hypercholesterolemia; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardium; Nitric Oxide; Oxidative Stress; Protein Kinase Inhibitors; Rabbits; rho-Associated Kinases; Superoxide Dismutase; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2017 |
Inhibition of RHO Kinase by Fasudil Attenuates Ischemic Lung Injury After Cardiac Arrest in Rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Lung Injury; Animals; Blotting, Western; Cytokines; Enzyme Inhibitors; Heart Arrest; Inflammation; Ischemia; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Superoxide Dismutase | 2018 |